Similar articles

• [Titer of antibodies against Burkitt's lymphoma virus in Burkitt's lymphoma and other diseases].

  Gunven P. Gunven P. G Batteriol Virol Immunol Ann Osp Maria Vittor Torino. 1972 Sep-Oct;65(9):228-32. G Batteriol Virol Immunol Ann Osp Maria Vittor Torino. 1972. PMID: 4353758 Italian. No abstract available.
• Epstein-Barr virus-immune complexes in postmortem kidneys from African patients with Burkitt's lymphoma and American patients with and without lymphoma.

  Sutherland JC, Olweny CL, Levine PH, Mardiney MR Jr. Sutherland JC, et al. J Natl Cancer Inst. 1978 May;60(5):941-6. doi: 10.1093/jnci/60.5.941. J Natl Cancer Inst. 1978. PMID: 205665 No abstract available.
• Changes in antibodies to Epstein-Barr virus-associated antigens with the development of Burkitt's lymphoma.

  Magrath IT, Henle W. Magrath IT, et al. IARC Sci Publ (1971). 1975;(11 Pt 2):275-81. IARC Sci Publ (1971). 1975. PMID: 191371 No abstract available.
• The Epstein-Barr Virus (EBV) in Burkitt's lymphoma and nasopharyngeal carcinoma.

  Henle W, Henle G. Henle W, et al. Ann Clin Lab Sci. 1974 Mar-Apr;4(2):109-14. Ann Clin Lab Sci. 1974. PMID: 4362218 Review. No abstract available.
• [Immunology of Epstein-Barr virus in lymphoproliferative diseases].

  Bachmann AE, Giraudo Conesa LC, Braun M. Bachmann AE, et al. Medicina (B Aires). 1974 Mar;34(2):157-66. Medicina (B Aires). 1974. PMID: 4368156 Review. Spanish. No abstract available.